Novel, Low Cost, Highly Effective, Handmade Steroid Pellets for Experimental Studies

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Sahores, Ana ^a   Luque, Guillermina M ^a   Wargon, Victoria ^a   May, María ^a   Molinolo, Alfredo ^b   Becu Villalobos, Damasia ^a   Lanari, Claudia ^a   Lamb, Caroline A ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIVE AGENT; DIMETICONE; ESTRADIOL; FASTIX; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE; PROGESTERONE; PROLACTIN; SILASTIC; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CONTROLLED STUDY; DOWN REGULATION; DRUG BLOOD LEVEL; DRUG COST; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MANUFACTURE; DRUG PELLET; EXPERIMENTAL STUDY; FEMALE; HANDMADE STEROID PELLET; HISTOPATHOLOGY; HORMONE ACTION; HORMONE DEFICIENCY; HORMONE DEPENDENCE; HORMONE SUBSTITUTION; IMMUNOHISTOCHEMISTRY; LUTEINIZING HORMONE BLOOD LEVEL; MAMMARY GLAND; MOUSE; NONHUMAN; OVARIECTOMY; PROLACTIN BLOOD LEVEL; RADIOIMMUNOASSAY; TREATMENT DURATION; UTERUS WEIGHT;

ANIMALS; BODY WEIGHT; CELL DIVISION; CHEMISTRY, PHARMACEUTICAL; DRUG COSTS; ESTRADIOL; FEMALE; GONADAL STEROID HORMONES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; ORGAN SIZE; PROGESTERONE; RADIOIMMUNOASSAY;

EID: 84877779841     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064049     Document Type: Article

References (32)

1. Gadducci A, Genazzani AR, (1997) Steroid hormones in endometrial and breast cancer. Review. Eur J Gynaecol Oncol 18: 371-378.
2. Chang K, Lubo Z, (2008) Review article: steroid hormones and uterine vascular adaptation to pregnancy. Reprod Sci 15: 336-348.
3. Theodorsson A, Hilke S, Rugarn O, Linghammar D, Theodorsson E, (2005) Serum concentrations of 17beta-estradiol in ovariectomized rats during two times six weeks crossover treatment by daily injections in comparison with slow-release pellets. Scand J Clin Lab Invest 65: 699-705.
4. Strom JO, Theodorsson E, Theodorsson A, (2008) Order of magnitude differences between methods for maintaining physiological 17beta-oestradiol concentrations in ovariectomized rats. Scand J Clin Lab Invest 68: 814-822.
5. Ingberg E, Theodorsson A, Theodorsson E, Strom JO, (2012) Methods for long-term 17beta-estradiol administration to mice. Gen Comp Endocrinol 175: 188-193.
6. Li JJ, Weroha SJ, Lingle WL, Papa D, Salisbury JL, (2004) Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats. Proc Natl Acad Sci U S A 101: 18123-18128.
7. Bronson FH, (1976) Serum FSH, LH, and prolactin in adult ovariectomized mice bearing silastic implants of estradiol: responses to social cues. Biol Reprod 15: 147-152.
8. Elsaesser F, Hayashi S, Parvizi N, Ellendorff F, (1989) In vitro characterization of secretion rates from silastic micropellets containing estradiol. Steroids 54: 159-168.
9. Dziuk PJ, Cook B, (1966) Passage of steroids through silicone rubber. Endocrinology 78: 208-211.
10. Strom JO, Theodorsson E, Holm L, Theodorsson A, (2010) Different methods for administering 17beta-estradiol to ovariectomized rats result in opposite effects on ischemic brain damage. BMC Neurosci 11: 39.
11. Kivisaari J, Niinikoski J, (1973) Use of silastic tube and capillary sampling technic in the measurement of tissue PO 2 and PCO 2. Am J Surg 125: 623-627.
12. Institute of Laboratory Animal Resources CoLSNRC (1996) Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, D.C.
13. Lanari C, Lamb CA, Fabris VT, Helguero LA, Soldati R, (2009) The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer. Endocr Relat Cancer 16: 333-350.
14. Lamb CA, Helguero LA, Giulianelli S, Soldati R, Vanzulli SI, (2005) Antisense oligonucleotides targeting the progesterone receptor inhibit hormone-independent breast cancer growth in mice. Breast Cancer Res 7: R1111-R1121.
15. Mejia M, Gonzalez-Iglesias A, Diaz-Torga GS, Villafane P, Formia N, (1999) Effects of continuous ivermectin treatment from birth to puberty on growth and reproduction in dairy heifers. J Anim Sci 77: 1329-1334.
16. Luque GM, Perez-Millan MI, Ornstein AM, Cristina C, Becu-Villalobos D, (2011) Inhibitory effects of antivascular endothelial growth factor strategies in experimental dopamine-resistant prolactinomas. J Pharmacol Exp Ther 337: 766-774.
17. Lacau-Mengido IM, Mejia ME, Diaz-Torga GS, Gonzalez IA, Formia N, (2000) Endocrine studies in ivermectin-treated heifers from birth to puberty. J Anim Sci 78: 817-824.
18. Wargon V, Helguero LA, Bolado J, Rojas P, Novaro V, (2009) Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas. Breast Cancer Res Treat 116: 449-460.
19. Vanzulli SI, Soldati R, Meiss R, Colombo L, Molinolo AA, (2005) Estrogen or antiprogestin treatment induces complete regression of pulmonary and axillary metastases in an experimental model of breast cancer progression. Carcinogenesis 26: 1055-1063.
20. Giulianelli S, Vaque JP, Soldati R, Wargon V, Vanzulli SI, (2012) Estrogen Receptor Alpha Mediates Progestin-Induced Mammary Tumor Growth by Interacting with Progesterone Receptors at the Cyclin D1/MYC Promoters. Cancer Res 72: 2416-2427.
21. Suarez C, García Tornadú I, Khalil W, Becu-Villalobos D, (2002) Dehydroepiandrosterone treatment attenuates oestrogen-induced pituitary hyperplasia. J Endocrinol 174: 447-454.
22. Sinha YN, Selby FW, Lewis UJ, VanderLaan WP, (1972) Studies of prolactin secretion in mice by a homologous radioimmunoassay. Endocrinology 91: 1045-1053.
23. Cohen PE, Milligan SR, (1993) Silastic implants for delivery of oestradiol to mice. J Reprod Fertil 99: 219-223.
24. Symons AM, Cunningham NF, Saba N, Millar PG, (1974) Circulating progesterone levels in anoestrous sheep with silicone rubber progesterone implants. J Reprod Fertil 41: 475-477.
25. Saba N, Cunningham NF, Symons AM, Millar PG, (1975) The effect of progesterone implants on ovulation and plasma levels of LH, FSH and progesterone in anoestrous ewes. J Reprod Fertil 44: 59-68.
26. Salem HF, (2010) Sustained-release progesterone nanosuspension following intramuscular injection in ovariectomized rats. Int J Nanomedicine 5: 943-954.
27. Cristina C, Diaz-Torga G, Baldi A, Gongora A, Rubinstein M, (2005) Increased pituitary vascular endothelial growth factor-a in dopaminergic D2 receptor knockout female mice. Endocrinology 146: 2952-2962.
28. Tibbetts TA, Mendoza-Meneses M, O'Malley BW, Conneely OM, (1998) Mutual and intercompartmental regulation of estrogen receptor and progesterone receptor expression in the mouse uterus. Biol Reprod 59: 1143-1152.
29. Aupperlee MD, Haslam SZ, (2007) Differential hormonal regulation and function of progesterone receptor isoforms in normal adult mouse mammary gland. Endocrinology 148: 2290-2300.
30. Montero GG, Vanzulli SI, Cerliani JP, Bottino MC, Bolado J, et al. (2007) Association of estrogen receptor alpha and progesterone receptor A expression with hormonal mammary carcinogenesis: role of the host microenvironment. Breast Cancer Res 9: R22.
31. Wang S, Counterman LJ, Haslam SZ, (1990) Progesterone action in normal mouse mammary gland. Endocrinology 127: 2183-2189.
32. Gardner WU, Allen E, (1939) Malignant and Non-malignant Uterine and Vaginal Lesions in Mice Receiving Estrogens and Estrogens and Androgens Simultaneously. Yale J Biol Med 12: 213-234.